These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2088662)

  • 21. DNA polymorphism of the C2 locus.
    Bentley DR; Campbell RD; Cross SJ
    Immunogenetics; 1985; 22(4):377-90. PubMed ID: 2997031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alleles of the second component of complement (C2) in insulin-dependent diabetes mellitus.
    Dornan J; Allan P; Noel EP; Sampson L; Farid NR
    Hum Hered; 1981; 31(4):211-3. PubMed ID: 7287012
    [No Abstract]   [Full Text] [Related]  

  • 23. Association between allotypes of complement components C2, BF, C4 of HLA class III and cerebral stroke.
    Wang C; Zhao XZ; Chen SQ; Wang ZH
    J Tongji Med Univ; 1992; 12(2):90-3. PubMed ID: 1433424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphism of the second component of human complement (C2). Observation of the rare phenotype (C2 2 (= C2 B) and data on the localization of the C2 locus in the HLA region.
    Dewald G; Rittner C
    Vox Sang; 1979; 37(1):47-54. PubMed ID: 40340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restriction fragment length polymorphism analysis of factor B and C2 genes in H-2 recombinant mouse strains.
    Lafuse WP; Castle L; David CS
    Immunogenetics; 1990; 31(4):275-7. PubMed ID: 1970336
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic variability of the MHC class III complement proteins C2, BF, C4A and C4B in southern Brazil.
    de Messias IT; Reis A; de Almeida PT; Mauff G
    Exp Clin Immunogenet; 1994; 11(4):192-6. PubMed ID: 7857665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-linked complement polymorphisms (C2, BF) in psoriasis.
    Dewald G; Lange CE; Schmeel E; Kreysel HW
    Arch Dermatol Res; 1983; 275(5):301-4. PubMed ID: 6559061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structure and genetics of the C2 and factor B genes.
    Campbell RD; Bentley DR
    Immunol Rev; 1985 Oct; 87():19-37. PubMed ID: 3902623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphism.
    Woods DE; Edge MD; Colten HR
    J Clin Invest; 1984 Aug; 74(2):634-8. PubMed ID: 6086718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism of properdin factor B in Japanese. Description of a rare variant and data of association with HLA and C2.
    Tokunaga K; Araki C; Juji T; Omoto K
    Hum Genet; 1982; 60(1):42-5. PubMed ID: 6918356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA polymorphism of the C2 and factor B genes. Detection of a restriction fragment length polymorphism which subdivides haplotypes carrying the C2C and factor B F alleles.
    Cross SJ; Edwards JH; Bentley DR; Campbell RD
    Immunogenetics; 1985; 21(1):39-48. PubMed ID: 2981769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [B, C2 and C4 complement factors, the HLA system and diseases. Genetic relation].
    Doutre MS
    Pathol Biol (Paris); 1983 Sep; 31(7):622-30. PubMed ID: 6355995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Component deficiencies. 3. The second component.
    Ruddy S
    Prog Allergy; 1986; 39():250-66. PubMed ID: 2882521
    [No Abstract]   [Full Text] [Related]  

  • 34. Structure organization and expression of the major histocompatibility class III genes.
    Colten HR
    Ann N Y Acad Sci; 1985; 458():269-76. PubMed ID: 3911849
    [No Abstract]   [Full Text] [Related]  

  • 35. Complement genetics in relation to HLA.
    Lachmann PJ; Hobart MJ
    Br Med Bull; 1978 Sep; 34(3):247-52. PubMed ID: 363219
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic polymorphisms of HLA class III and GLO1 in Chinese Yao nationality.
    Wang C; Tian YW; Wu XW; Zhao XZ
    Gene Geogr; 1990 Apr; 4(1):29-34. PubMed ID: 2278900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of allotypes of HLA class III (C2, BF and C4) in patients with schizophrenia.
    Wang C; Jian BX; Jiang XD; Zhao XZ
    Chin Med J (Engl); 1992 Apr; 105(4):316-8. PubMed ID: 1618015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement components C2, C3, and C4 (C4A and C4B) and BF polymorphisms in populations of the Indian subcontinent.
    Ad'hiah AH; Papiha SS
    Hum Biol; 1996 Oct; 68(5):755-76. PubMed ID: 8908800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are major histocompatibility system class III products independent markers for susceptibility to rheumatoid arthritis?
    Dyer PA; Thomson W; Sanders PA; Grennan DM
    Dis Markers; 1986 Jun; 4(1-2):151-5. PubMed ID: 3330696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetics of complement.
    Raum D; Donaldson VH; Rosen FS; Alper CA
    Curr Top Hematol; 1980; 3():111-74. PubMed ID: 7035077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.